Leprosy vaccine candidate, LepVax, provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection in animals: Study
by Press Release from Outbreak News Today on (#3NTCG)
A publication in Nature Partner Journals (npj) Vaccines indicates that post-exposure prophylaxis with LepVax, IDRI's leprosy vaccine candidate, not only appears safe but, unlike BCG (a tuberculosis vaccine that provides some protection against leprosy), alleviates and delays the neurologic disruptions caused by Mycobacterium leprae infection in nine-banded armadillos. This is an important finding because armadillos are the only other host ["]
The post Leprosy vaccine candidate, LepVax, provides effective pre-exposure and post-exposure prophylaxis of M. leprae infection in animals: Study appeared first on Outbreak News Today.